Search Results - Pirkmajer, KP

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Ouabain Suppresses IL-6/STAT3 Signaling and Promotes Cytokine Secretion in Cultured Skeletal Muscle Cells

    Ouabain Suppresses IL-6/STAT3 Signaling and Promotes Cytokine Secretion in Cultured Skeletal Muscle Cells by Pirkmajer, Sergej, Bezjak, Katja, Matkovič, Urška, Dolinar, Klemen, Jiang, Lake Q., Miš, Katarina, Gros, Katarina, Milovanova, Kseniya, Pirkmajer, Katja Perdan, Marš, Tomaž, Kapilevich, Leonid, Chibalin, Alexander V.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice

    Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice by Christiansen, Sara Nysom, Horskjær Rasmussen, Simon, Pons, Marion, Michelsen, Brigitte, Glintborg, Bente, Gudbjornsson, Bjorn, Grondal, Gerdur, Vencovsky, Jiri, Loft, Anne Gitte, Rotar, Ziga, Pirkmajer, Katja Perdan, Nissen, Michael J., Baranová, Jana, Macfarlane, Gary J., Jones, Gareth T., Iannone, Florenzo, Caporali, Roberto, Laas, Karin, Vorobjov, Sigrid, Giuseppe, Daniela Di, Olofsson, Tor, Provan, Sella Aarrestad, Fagerli, Karen Minde, Castrejon, Isabel, Otero-Varela, Lucia, van de Sande, Marleen, van der Horst-Bruinsma, Irene, Nordström, Dan, Kuusalo, Laura, Bernardes, Miguel, Hetland, Merete Lund, Østergaard, Mikkel, Midtbøll Ørnbjerg, Lykke

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    Ouabain suppresses IL-6 signalling in cultured skeletal muscle cells

    Ouabain suppresses IL-6 signalling in cultured skeletal muscle cells by Bezjak, K, Matkovic, U, Mis, K, Dolinar, K, Pirkmajer, KP, Mars, T, Chibalin, A, Pirkmajer, S

    Get full text
    Conference Proceeding
    Save to List
    Saved in:
  4. 4
    The Impact of Smoking Status on One Year Secukinumab Retention Rate in 1,684 Patients with PsA: Real-World Results from the EuroSpA Collaboration

    The Impact of Smoking Status on One Year Secukinumab Retention Rate in 1,684 Patients with PsA: Real-World Results from the EuroSpA Collaboration by Ahmadzay, ZF, Georgiadis, S, Pons, M, Hetland, M, Glintborg, B, Heberg, J, Christiansen, SN, Rasmussen, SH, Loft, AG, Castrejon, I, Otero-Valera, L, Zavada, J, Pavelka, K, Relas, H, Kuusalo, L, Moeller, B, Nissen, M, Rotar, Z, Pirkmajer, KP, Oliveira, DS, Cruz-Machado, AR, Michelsen, B, Kristianslund, E, Gudbjornsson, B, Grondal, GM, Laas, K, Hellamand, P, Sari, I, Di Giuseppe, D, Ostergaard, M, Ornbjerg, L

    Get full text
    Conference Proceeding
    Save to List
    Saved in:
  5. 5
    Do Long-term Patient-reported Outcomes Improve Similarly in Psoriatic Arthritis and Axial Spondyloarthritis Patients Treated with Secukinumab? Results from the EuroSpA Collaboration

    Do Long-term Patient-reported Outcomes Improve Similarly in Psoriatic Arthritis and Axial Spondyloarthritis Patients Treated with Secukinumab? Results from the EuroSpA Collaboratio... by Pons, M, Rasmussen, SH, Christiansen, SN, Michelsen, B, Glintborg, B, Gudbjornsson, B, Grondal, GM, Vencovsky, J, Loft, AG, Rotar, Z, Pirkmajer, KP, Nissen, M, Moeller, B, Macfarlane, G, Jones, GT, Iannone, F, Caporali, RF, Laas, K, Vorobjov, S, Di Giuseppe, D, Coskun, BN, Yagiz, B, Provan, S, Fagerli, K, Castrejon, I, Otero-Valera, L, van de Sande, M, Van der Horst-Bruinsma, I, Nordstrom, D, Kuusalo, L, Vieira-Sousa, E, Bernardes, M, Olofsson, T, Baranov, J, Hetland, M, Ostergaard, M, Ornbjerg, L

    Get full text
    Conference Proceeding
    Save to List
    Saved in:

Search Tools: